Publications by authors named "Jay Lichter"

Claim this Profile
M
Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis.
Atsuo Kanno, Takuya Kito, Masashi Maeda, Shanni Yamaki, Yasushi Amano, Jay Lichter

Nat Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration.
Nathan L Mata, Jay B Lichter, Roger Vogel, Yun Han, Tam V Bui

Retina· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of dexamethasone solution following intratympanic injection in guinea pig and sheep.
Xiaobo Wang, Rayne Fernandez, Luis Dellamary, Anne Harrop, Qiang Ye, Jay Lichter

Audiol Neurootol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders.
Fabrice Piu, Xiaobo Wang, Rayne Fernandez, Luis Dellamary, Anne Harrop, Jay Lichter

Otol Neurotol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach.
Xiaobo Wang, Luis Dellamary, Rayne Fernandez, Anne Harrop, Elizabeth M Keithley, Jay Lichter

Audiol Neurootol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vanadium treatment of type 2 diabetes: a view to the future.
Katherine H Thompson, Jay Lichter, Carl LeBel, Michael C Scaife, John H McNeill

J Inorg Biochem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases.
Roxana A Radu, Yun Han, Tam V Bui, Steven Nusinowitz, Dean Bok, Jay Lichter

Invest Ophthalmol Vis Sci· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis